Last reviewed · How we verify
NCT03091504
Evaluation on the Efficacy of Bronchodilator Nebulization Via High Flow Nasal Cannula
NA trial testing High flow nasal cannula in High Flow Nasal Cannula in 42 participants. Completed in 31 March 2018.
31 March 2018
Quick facts
| Lead sponsor | Rush University Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 42 |
| Start date | 4 September 2017 |
| Primary completion | 31 March 2018 |
| Estimated completion | 31 March 2018 |
| Sites | 1 location across China |
Drugs / interventions tested
- High flow nasal cannula
- Albuterol Sulfate — full drug profile →
Conditions studied
- High Flow Nasal Cannula — all drugs for High Flow Nasal Cannula →
Sponsor
Rush University Medical Center
Who can join
Adults 18 to 90, any sex, with High Flow Nasal Cannula. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
High-humidity nasal cannula (HFNC) has been shown to be effective in improving oxygenation and avoiding intubation in multiple randomized control trials, it is also suitable and feasible for long term use. Aerosol delivery via HFNC will minimize interruptions and improve patient compliance, bench study and radionuclide imaging study done in healthy volunteers demonstrated that aerosol can be effectively delivered using HFNC. This study aims to evaluate the efficacy of bronchodilator delivered via HFNC in chronic pulmonary obstructive disease or asthma patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03091504
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High flow nasal cannula
Trials testing the same drug.
- NCT06069817 — Impact of High Flow Therapy on Complications Related to Airway Stenting · NA · unknown
- NCT05918575 — Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients · NA · recruiting
- NCT05532033 — High Flow Nasal Cannula and Diaphragmatic Function · NA · completed
- NCT04842253 — HFNC Vs LFNC in Patients with AF Undergoing RFCA Under Deep Sedation. · NA · terminated
- NCT04849520 — High Flow Nasal Cannula for Safe Apnea · NA · completed
Other recruiting trials for High Flow Nasal Cannula
Currently open trials in the same condition.
- NCT07159022 — High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy · NA · recruiting
Other Rush University Medical Center trials
Trials by the same sponsor.
- NCT07278076 — Clinical Decision-Making During FEES: The Impact of Residue Amount and Location · NA · not yet recruiting
- NCT07088120 — PRECISION-CPR: PRecision-Controlled Ventilation in CPR · NA · not yet recruiting
- NCT06894719 — Oral Tranexamic Acid After Total Knee Arthroplasty · Phase 4 · not yet recruiting
- NCT06229392 — A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer · Phase 1 · withdrawn
- NCT07452406 — Protocolized Weaning of High-Flow Nasal Cannula in Adult Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03091504 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rush University Medical Center
- Last refreshed: 4 April 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03091504.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing